Cenobamate in Real‐Word Scenario: Results on Efficacy, Side Effects, and Retention Rate in a Single Center Retrospective Study

ABSTRACT Background Pharmacoresistance imposes a high burden on people with epilepsy (PWE). Recently authorized cenobamate (CNB) offers new hope with high efficacy reported in phase III and early real‐world studies. Here, we present data from a reasonably sized monocentric cohort, complementing the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mostafa Badr, Christoph Helmstaedter, Susanna Moskau‐Hartmann, Jan Pukropski, Juri‐Alexander Witt, Theodor Rüber, Karmele Olaciregui Dague, Tobias Baumgartner, Michael Rademacher, Rainer Surges, Randi vonWrede
Format:	Article
Language:	English
Published:	Wiley 2025-05-01
Series:	Brain and Behavior
Subjects:	cenobamate efficacy real‐world data retention rate side effects
Online Access:	https://doi.org/10.1002/brb3.70567
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Cenobamate in Real‐Word Scenario: Results on Efficacy, Side Effects, and Retention Rate in a Single Center Retrospective Study

Similar Items